Dr. Rachel Knox, MD, MBA

Dr. Rachel Knox, MD, MBA is a cannabinoid medicine specialist and clinical endocannabinologist who received her medical and business degrees from Tufts School of Medicine after completing her undergraduate studies at Duke. She trained in family and integrative medicine before pursuing additional study in the areas of functional medicine, cannabinology, and endocannabinology.

Along with her family, Dr. Rachel founded Doctors Knox, Inc., American Cannabinoid Clinics, and Pivital Edu to advance education in cannabinoid medicine and in the clinical care of the endocannabinoidome.

Dr. Rachel is also a policy and regulatory consultant on cannabis and psychedelics, and her commitment to reform extends into educating communities of color about the roles cannabis, psychedelics, and other plant medicines can play in addressing the Minority Health Disparity Gap, and the broader way in which these plants can impact the total wellbeing of these communities through health equity.

She is co-founder and president of the Cannabis Health Equity Movement™ (CHEM), and chair of the Association for Cannabis Health Equity and Medicine (ACHEM) and CHEM Allyance. She serves her home state of Oregon as the immediate past chair of the Oregon Cannabis Commission, member of Portland's Cannabis Policy Oversight Team, member of Oregon’s Psilocybin Advisory Board, and board member for NuLeaf PDX; and also sits on several national boards including Cannabis Regulators of Color Coalition (CRCC), Doctors for Cannabis Regulation (DFCR), Minority Cannabis Business Association (MCBA), American Academy of Cannabinoid Medicine (AACM), and US Cannabis Council.